Not yet medically reviewed, information on this site is in preparation and has not been verified by a medical reviewer.
Legality · Memantine

Memantine in Timor-Leste: not individually verified

Also known as: namenda

Not individually verified

We have not confirmed that Memantine specifically is scheduled in Timor-Leste, so this page gives no legal status. Publishing a guess here would be worse than publishing nothing. What we do know is the governing national drug law, below.

What is on record
Not confirmed. A direct search of Anexo II to Lei n.º 2/2017, de 25 de Janeiro, for "memantina" returned no match anywhere in Tables I to VI. Memantine, an NMDA-receptor antagonist used for Alzheimer's disease rather than a recognised drug of abuse at the time of this law's enactment, is not a "droga" under article 2(d) and not a "precursor" under article 2(e) on the schedule as printed. This table-absence is not treated here as a settled negative answer, because Lei n.º 2/2017 does not close itself: article 3(3) allows the tables to be altered by law or updated in line with changes to the international Conventions, and whether that updating clause self-executes without a further legislative act is not resolved on the text read. No amending law has been located this session, and no systematic search of the Jornal da República since 2017 was completed.

Confirm directly with Timor-Leste’s national drug authority or your own embassy before you rely on anything.

This page is deliberately excluded from search indexing and from our sitemap. Only confirmed, individually verified statuses are published as indexable pages.